Home Forums Main Forum Media & News BMS Looking for people to go public – PBS Launch

Viewing 3 posts - 1 through 3 (of 3 total)
  • Author
    Posts
  • #10765
    Avatar photoemilio
    • Guardian Angel
    • ★★★★★
    @emilio

    Hi Chester

    Im happy to be involved, lm recently out via a previous SMH article. Treated with peg/riba and a trial PI back in 2007 for 63 weeks. Now just finishing up 18 weeks of sof/dac generics. Would like to know a bit more about the slant etc but happy to discuss with BMS. Em

    #10769
    Avatar photoChester
    • Guardian Angel
    • ★★★★★
    @chester

    Great I’ll PM her info.

    As for the slant, I’ve said pretty much all I know. I suggest discuss it with her further. I found her kinda naive (in a sweet, innocent way) and pretty oblivious to the politics behind it all. She seemed to genuinely not get my gentle nudges that they should compete more with their opposition where they can (led vs dac) because some competition is sorely needed.

    I think it’s the journos you need to be most wary of and the spin they may potentially try to put on it. When the PBS listing was announced, that stupid Deb woman on the Today show actually asked the health minister if everybody would be able to get the drugs “no matter how they contracted the disease”. What a low life! You could try asking the journo if you could fact check the story for accuracy before it’s published/aired. But I wouldn’t be confident of them agreeing.

    #10799
    avatar876.jpegGaj
    • Guardian Angel
    • ★★★★★
    @gaj

    Hi Chester, please check your PMs

    ……for the rest of you: No, I’m not planning on removing my shades and staring at the spotlights B)


    G3a since ’78 – Dx ’12 – F4 (2xHCC)
    24wk Tx – PEG/Riba/Dac 2013 relapsed
    24wk Tx – Generic Sof/Dac/Riba 2015/16 relapsed
    16wk Tx – 12/01/17 -> 03/05/17 NS3/NS5a + Generic Sof
    SVR7 – 22/06/17 UND
    SRV12 – 27/07/17 UND
    SVR24 – 26/10/17 UND
    :cheer: :cheer: :cheer:

Viewing 3 posts - 1 through 3 (of 3 total)
  • You must be logged in to reply to this topic.